Community Pharmacy England (CPE) - News updates


Respecting Patient Choice for Pharmacy EPS Nominations

In recent months, Community Pharmacy England has received a number of concerns about EPS pharmacy nominations and re-nominations without patient consent, and wishes to remind pharmacy owners of the relevant Terms of Service requirements and the importance of patient choice of nominated pharmacy. Terms of Service The Terms of Service provide that a pharmacy owner [...] The post Respecting Patient Choice for Pharmacy EPS Nominations appeared first on Community Pharmacy England.

November 2025 Price Concessions – 6th Update

The Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department. [...] The post November 2025 Price Concessions – 6th Update appeared first on Community Pharmacy England.

Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free)

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...] The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.

6 products re-classified as special containers from December 2025

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 December 2025. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose ampoules Teva UK Ltd 20 unit dose    [...] The post 6 products re-classified as special containers from December 2025 appeared first on Community Pharmacy England.

November 2025 Price Concessions 5th Update

The Department of Health and Social Care (DHSC) has today (27/11/2025) confirmed the following list of price concessions for November 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £46.65 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dexamethasone 500microgram tablets 28 £1.87 Fenofibrate micronised 67mg capsules 90 £8.69 Lansoprazole 30mg orodispersible tablets [...] The post November 2025 Price Concessions 5th Update appeared first on Community Pharmacy England.

Use of ‘FS’ endorsement extended to Tuberculosis (TB) treatments

From 1 December 2025, use of the ‘FS’ prescriber endorsement has been extended to treatments used in the management of tuberculosis (TB) and latent TB infections, including the effects of TB and the adverse effects from TB treatment. Community Pharmacy England has worked closely with DHSC over the past year to secure a workable mechanism [...] The post Use of ‘FS’ endorsement extended to Tuberculosis (TB) treatments appeared first on Community Pharmacy England.

Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited)

MHRA Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited) Drug alert number: EL(25)A/51 Date issued: 27 November 2025 Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information. DMRC reference number: DMRC – [...] The post Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited) appeared first on Community Pharmacy England.

Chancellor delivers Budget speech

The Chancellor announced her Budget in Parliament today (26th November), setting out the Government’s spending plans for the coming financial year. In terms of healthcare, the Budget commits £300 million of investment in technology to improve patient service and 250 new neighbourhood health centres. The Chancellor went on to say that the Government would be “expanding more [...] The post Chancellor delivers Budget speech appeared first on Community Pharmacy England.

DHSC publishes medicines shortages leaflets and posters

As part of ongoing work and plans to improve the management of medicines supply issues, the Department of Health and Social Care (DHSC) and NHS England have published leaflets and posters for patients, community pharmacies and general practices about what to do when faced with medicine supply issues. These resources can be found on the [...] The post DHSC publishes medicines shortages leaflets and posters appeared first on Community Pharmacy England.

November 2025 Price Concessions – 4th Update

The Department of Health and Social Care (DHSC) has today (26/11/2025) confirmed the following list of price concessions for November 2025: Drug Pack size Price concession Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 0.4ml unit dose preservative free 30 £9.90 Ciprofloxacin 500mg tablets 10 £6.72 Clarithromycin 125mg/5ml oral suspension 70 £10.19 Clarithromycin 250mg/5ml oral suspension 70 £17.80 [...] The post November 2025 Price Concessions – 4th Update appeared first on Community Pharmacy England.